cigna glp 1 program is ending employee coverage for GLP-1 weight-loss drugs like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Cigna dropping all GLP-1 coverage

Rotating by at least one inch from the previous injection site within the same region is a minimum standard

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

Comprehensive Program Support Our medical weight loss program includes medication guidance, customizable treatment plans, and ongoing support designed around your individual goals

The question isn't whether India can participate, but how it can emerge as a global leader in complex biologics manufacturing

Retatrutide, Eli Lillys next-generation triple-action therapy, has once again demonstrated meaningful efficacy in clinical trials

While we routinely perform lymphatic surgery for lymphedema, many patients are not candidates for surgery because of high BMI or do not want surgical intervention